Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Souris And NotP. Shashidharan

List of bibliographic references

Number of relevant bibliographic references: 24.
Ident.Authors (with country if any)Title
000488 Benjamin Dehay [France] ; Erwan Bezard [France]New Animal Models of Parkinson's Disease
000731 Erwan Bezard [France] ; Serge Przedborski [États-Unis]A Tale on Animal Models of Parkinson's Disease
000994 Hans C. Scholle [Allemagne] ; H. A. Jinnah [États-Unis] ; Dirk Arnold [Allemagne] ; Frank H. W. Biedermann [Allemagne] ; Bernd Faenger [Allemagne] ; Roland Grassme [Allemagne] ; Ellen J. Hess [États-Unis] ; Nikolaus P. Schumann [Allemagne]Kinematic and Electromyographic Tools for Characterizing Movement Disorders in Mice
001146 Thomas L. Shirley [États-Unis] ; Lekha M. Rao [États-Unis] ; Ellen J. Hess [États-Unis] ; H. A. Jinnah [États-Unis]Paroxysmal Dyskinesias in Mice
001204 Mitchell F. Brin [États-Unis] ; Cynthia L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; Francis Lai [États-Unis] ; Markus Naumann [Allemagne]Long-Term Treatment with Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay
001510 Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada]Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle
001589 Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Manuela Neumann [Allemagne] ; Philipp J. Kahle [Allemagne] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Microglial Activation Mediates Neurodegeneration Related to Oligodendroglial α-Synucleinopathy : Implications for Multiple System Atrophy
001614 Anthony P. Nicholas [États-Unis]Levodopa-induced hyperactivity in mice treated with 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine
001650 Nadia Stefanova [Autriche] ; Martin Köllensperger [Autriche] ; Monika Hainzer [Autriche] ; Angela Cenci [Suède] ; Werner Poewe [Autriche] ; Gregor Karl Wenning [Autriche]High dose Levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
001D91 Dirk Dressler [Allemagne] ; M. Lange [Allemagne] ; Hans Bigalke [Allemagne]Mouse diaphragm assay for detection of antibodies against botulinum toxin type B
001E82 Jason D. Dapper [États-Unis] ; Monica J. Justice [États-Unis]Defining the breakpoints of the Quakingviable mouse mutation reveals a duplication from a Parkin intron
001F37 Gwenaelle Fillon [Allemagne] ; Philipp J. Kahle [Allemagne]Alpha-synuclein transgenic mice : Relevance to multiple system atrophy
002011 H. A. Jinnah [États-Unis] ; Ellen J. Hess [États-Unis] ; Mark S. Ledoux [États-Unis] ; Nutan Sharma [États-Unis] ; Mark G. Baxter [Royaume-Uni] ; Mahlon R. Delong [États-Unis]Rodent models for dystonia research : Characteristics, evaluation, and utility
002120 Paul J. Lockhart [États-Unis] ; Casey A. O'Farrell [États-Unis] ; Matthew J. Farrer [États-Unis]It's a double knock-out! The Quaking mouse is a spontaneous deletion of Parkin and Parkin co-regulated gene (PACRG)
002621 Johannes Schiefer [Allemagne] ; G. Bernhard Landwehrmeyer [Allemagne] ; Hans-Gerd Lüesse [Allemagne] ; Arne Sprünken [Allemagne] ; Christiane Puls [Allemagne] ; Anna Milkereit [Allemagne] ; Eva Milkereit [Allemagne] ; Christoph M. Kosinski [Allemagne]Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease
002A41 Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice
002B86 L. C. Abbott [États-Unis] ; M. Bump [États-Unis] ; A. Brandl [États-Unis] ; S. De Laune [États-Unis]Investigation of the role of the cerebellum in the myoclonic-like movement disorder exhibited by tottering mice
002C09 Rebecca J. Carter [Royaume-Uni] ; Mark J. Hunt [Royaume-Uni] ; A. Jennifer Morton [Royaume-Uni]Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene
002C43 H. A. Jinnah [États-Unis] ; J. P. Sepkuty [États-Unis] ; T. Ho [États-Unis] ; S. Yitta [États-Unis] ; T. Drew [États-Unis] ; J. D. Rothstein [États-Unis] ; E. J. Hess [États-Unis]Calcium channel agonists and dystonia in the mouse
002D69 F. Cardozo-Pelaez [États-Unis] ; SHIJIE SONG ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-RamosOxidative DNA damage in the aging mouse brain
002E65 E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël]Apomorphine protects against MPTP-induced neurotoxicity in mice
003130 M. Jaber [États-Unis] ; S. Jones ; B. Giros ; M. G. CaronThe dopamine transporter : A crucial component regulating dopamine transmission
003176 E. S. Simon [États-Unis]Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits
003198 G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine]Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024